Paper7477352
Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.
Turner M and 8 others. Nature, 1995. Cited by 619 papers, by iCite.
Cite this record
ConductScience Library. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Papers, record 7477352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7477352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| Enzyme Precursors | Major topic |
| Protein-Tyrosine Kinases | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Animals, Newborn | |
| Cell Differentiation | |
| Cell Line | |
| Cells, Cultured | |
| Chimera | |
| Crosses, Genetic | |
| Female | |
| Intracellular Signaling Peptides and Proteins | |
| Liver | |
| Mice | |
| Mice, Inbred C57BL | |
| Molecular Sequence Data | |
| Mutagenesis | |
| Purpura | |
| Syk Kinase | |
| T-Lymphocytes | |
| ZAP-70 Protein-Tyrosine Kinase |
Source PubMed
Cited by263
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 619 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42599887 | The Src-Family Kinases Hck, Fgr and Lyn Drive Immune Complex-Mediated Glomerulonephritis Through the Syk Tyrosine Kinase. | FASEB J | 2026 | https://conductscience.org/library/papers/42599887 | PubMed |
| 42400713 | Targeting SYK to alleviate MDSC-driven immunosuppression and augment anti-PD1 efficacy. | Sci China Life Sci | 2026 | https://conductscience.org/library/papers/42400713 | PubMed |
| 41837541 | Amphioxus tyrosine kinase SYK inhibits NF-κB activation through MyD88-dependent mechanism. | J Mol Cell Biol | 2026 | https://conductscience.org/library/papers/41837541 | PubMed |
| 41461956 | Platelet Membrane Receptors and Signalling Pathways. | Handb Exp Pharmacol | 2026 | https://conductscience.org/library/papers/41461956 | PubMed |
| 41114848 | Novel SYK Variant Causes Enhanced SYK Autophosphorylation and PI3K Activation in an Antibody-Deficient Patient. | J Clin Immunol | 2025 | https://conductscience.org/library/papers/41114848 | PubMed |
| 40779559 | Phosphorylation at Y317 on Syk negatively regulates both ITAM- and hemITAM-mediated signaling and function in platelets. | Blood Adv | 2025 | https://conductscience.org/library/papers/40779559 | PubMed |
| 40327098 | Germline mutations predispose a concurrent thymoma and diffuse large B-cell lymphoma. | Ann Hematol | 2025 | https://conductscience.org/library/papers/40327098 | PubMed |
| 39994019 | Tumor microenvironment as a novel therapeutic target for lymphoid leukemias. | Ann Hematol | 2025 | https://conductscience.org/library/papers/39994019 | PubMed |
| 39442513 | The mechanism of allosteric activation of SYK kinase derived from multiple phospho-ITAM-bound structures. | Structure | 2024 | https://conductscience.org/library/papers/39442513 | PubMed |
| 39140892 | Podosome Nucleation Is Facilitated by Multivalent Interactions between Syk and ITAM-containing Membrane Complexes. | J Immunol | 2024 | https://conductscience.org/library/papers/39140892 | PubMed |
| 38229397 | Spleen Tyrosine Kinase phosphorylates VE-cadherin to cause endothelial barrier disruption in acute lung injury. | J Biol Chem | 2023 | https://conductscience.org/library/papers/38229397 | PubMed |
| 38111569 | The selective inhibition of the Syk tyrosine kinase ameliorates experimental autoimmune arthritis. | Front Immunol | 2023 | https://conductscience.org/library/papers/38111569 | PubMed |
| 37212867 | New small molecules in dermatology: for the autoimmunity, inflammation and beyond. | Inflamm Res | 2023 | https://conductscience.org/library/papers/37212867 | PubMed |
| 37180910 | Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases. | Heliyon | 2023 | https://conductscience.org/library/papers/37180910 | PubMed |
| 36713401 | Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation. | Front Immunol | 2022 | https://conductscience.org/library/papers/36713401 | PubMed |
| 36346114 | A novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib) ameliorates lupus nephritis and serum-induced arthritis in murine models. | Clin Exp Immunol | 2023 | https://conductscience.org/library/papers/36346114 | PubMed |
| 36311757 | Metabolic requirements of Th17 cells and of B cells: Regulation and defects in health and in inflammatory diseases. | Front Immunol | 2022 | https://conductscience.org/library/papers/36311757 | PubMed |
| 35910221 | SYK Is Associated With Malignant Phenotype and Immune Checkpoints in Diffuse Glioma. | Front Genet | 2022 | https://conductscience.org/library/papers/35910221 | PubMed |
| 35846777 | 3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35846777 | PubMed |
| 35424194 | Characterizing the structure-activity relationships of natural products, tanshinones, reveals their mode of action in inhibiting spleen tyrosine kinase. | RSC Adv | 2021 | https://conductscience.org/library/papers/35424194 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SYK | 6850 | PubTator's text mining | https://conductscience.org/library/genes/6850 |
Source NCBI Gene
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | U25685 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7477352
GET https://conductscience.org/api/papers/v1/7477352/cited_by?page=2